Cargando…

Interrupting antiretroviral therapy in HIV cure trials during COVID-19: Adaptation to low transmission settings

Detalles Bibliográficos
Autores principales:	Lau, Jillian SY., Rasmussen, Thomas A., Lewin, Sharon R., Ehm, Adam, Martinez, Cipriano, Burnett, Craig, McMahon, James H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868108/ https://www.ncbi.nlm.nih.gov/pubmed/33585037 http://dx.doi.org/10.1016/j.jve.2021.100032

Ejemplares similares

Acceptability, motivation and the prospect of cure for people living with HIV and their healthcare providers in HIV cure-focused treatment interruption studies
por: Lau, Jillian S. Y., et al.
Publicado: (2020)

Balancing Statistical Power and Risk in HIV Cure Clinical Trial Design
por: Lau, Jillian S Y, et al.
Publicado: (2022)

Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerations
por: Garner, Samual A, et al.
Publicado: (2017)

HIV cure research in the time of COVID-19 - Antiretroviral therapy treatment interruption trials: A discussion paper
por: Fidler, S., et al.
Publicado: (2020)

Unwillingness of patients in Ghana to interrupt antiretroviral therapy for HIV cure research
por: Bonney, Evelyn Y., et al.
Publicado: (2021)

Antiretroviral therapy interruptions: impact on HIV treatment and transmission
por: Dubrocq, Gueorgui, et al.
Publicado: (2018)

Soluble immune checkpoints as correlates for HIV persistence and T cell function in people with HIV on antiretroviral therapy
por: Chiu, Chris Y., et al.
Publicado: (2023)

Predictors of SIV recrudescence following antiretroviral treatment interruption
por: Pinkevych, Mykola, et al.
Publicado: (2019)

Maternal CD4+ Cell Count Decline after Interruption of Antiretroviral Prophylaxis for the Prevention of Mother-to-Child Transmission of HIV
por: Ekouevi, Didier, et al.
Publicado: (2012)

Randomized Controlled Pilot Study of Antiretrovirals and a Behavioral Intervention for Persons With Acute HIV Infection: Opportunity for Interrupting Transmission
por: Miller, William C, et al.
Publicado: (2018)

HIV persistence in the CNS: the final frontier for a cure?
por: Lewin, Sharon R, et al.
Publicado: (2016)

Recruitment and ethical considerations in HIV cure trials requiring treatment interruption
por: Arnold, Michael P, et al.
Publicado: (2015)

1767. Structured Treatment Interruptions in HIV-Infected Patients Receiving Antiretroviral Therapy—Implications for Future HIV Cure Trials: A Systematic Review and Meta-analysis
por: Stecher, Melanie, et al.
Publicado: (2018)

The role of latency reversal in HIV cure strategies
por: Tanaka, Kiho, et al.
Publicado: (2022)

Time for revolution? Enhancing meaningful involvement of people living with HIV and affected communities in HIV cure-focused science
por: Lau, Jillian S.Y., et al.
Publicado: (2020)

Immunological predictors of CD4(+ )T cell decline in antiretroviral treatment interruptions
por: Seoane, Elena, et al.
Publicado: (2008)

Preventing Antiretroviral Treatment Interruptions among HIV/AIDS Patients in Africa
por: Mills, Edward J., et al.
Publicado: (2013)

Risk factors for mortality during antiretroviral therapy in older populations in resource-limited settings
por: O'Brien, Daniel, et al.
Publicado: (2016)

Interruption of Onchocerca volvulus transmission in Northern Venezuela
por: Convit, Jacinto, et al.
Publicado: (2013)

Design of trials for interrupting the transmission of endemic pathogens
por: Silkey, Mariabeth, et al.
Publicado: (2016)

A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infection
por: Kroon, Eugène D.M.B., et al.
Publicado: (2020)

Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment
por: Henderson, Gail E, et al.
Publicado: (2018)

The ethical case for placebo control in HIV-cure-related studies with ART interruption
por: Magalhaes, Monica, et al.
Publicado: (2022)

Potential Impact of Antiretroviral Chemoprophylaxis on HIV-1 Transmission in Resource-Limited Settings
por: Abbas, Ume L., et al.
Publicado: (2007)

Unplanned antiretroviral treatment interruptions in southern Africa: how should we be managing these?
por: Veenstra, Nina, et al.
Publicado: (2010)

Adherence to Antiretroviral Therapy and Acceptability of Planned Treatment Interruptions in HIV-Infected Children
por: Harrison, Linda, et al.
Publicado: (2012)

Compartmentalized HIV rebound in the central nervous system after interruption of antiretroviral therapy
por: Gianella, Sara, et al.
Publicado: (2016)

Finding a cure for HIV: will it ever be achievable?
por: Lewin, Sharon R, et al.
Publicado: (2011)

Measuring malaria endemicity from intense to interrupted transmission
por: Hay, Simon I, et al.
Publicado: (2008)

Interruption of vector transmission by native vectors and “the art of the possible”
por: Salvatella, Roberto, et al.
Publicado: (2013)

Effect of AGG Interruptions on FMR1 Maternal Transmissions
por: Villate, Olatz, et al.
Publicado: (2020)

Survey of Schistosomiasis in Saint Lucia: Evidence for Interruption of Transmission
por: Gaspard, Janice, et al.
Publicado: (2020)

Interrupting Malaria Transmission: Quantifying the Impact of Interventions in Regions of Low to Moderate Transmission
por: Gatton, Michelle L., et al.
Publicado: (2010)

GITR activation ex vivo impairs CD8 T cell function in people with HIV on antiretroviral therapy
por: Gubser, Céline, et al.
Publicado: (2023)

Rapid CD4 decline after interruption of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy in a resource-limited setting
por: Sungkanuparph, Somnuek, et al.
Publicado: (2007)

Poliovirus seroprevalence before and after interruption of poliovirus transmission in Kano State, Nigeria
por: Iliyasu, Zubairu, et al.
Publicado: (2016)

Dangerous medicines: Unproven AIDS cures and counterfeit antiretroviral drugs
por: Amon, Joseph J
Publicado: (2008)

Contribution of Environmental Surveillance Toward Interruption of Poliovirus Transmission in Nigeria, 2012–2015
por: Johnson Muluh, Ticha, et al.
Publicado: (2016)

Modeling of Experimental Data Supports HIV Reactivation from Latency after Treatment Interruption on Average Once Every 5–8 Days
por: Pinkevych, Mykola, et al.
Publicado: (2016)

Possible Interruption of Measles Virus Transmission, Uganda, 2006–2009
por: Baliraine, Frederick N., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_d8o9osmhrdddi8cgivkvbinuvk